# NovaResp Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/novaresp-technologies

- Industry: Software
- Headquarters: Halifax, Canada
- Website: www.novaresp.com
- Total disclosed funding: $5M
- Latest round: Seed (May 15, 2024)
- Investors on record: 2

## About

Based in Nova Scotia, Canada, and founded in 2016, NovaResp Technologies Inc operates as a healthcare technology firm. The company was founded by its CEO, Hamed Hanafi. In January 2023, NovaResp raised USD 0.25 million in grant funding from the Atlantic Canada Opportunities Agency. In January 2023, NovaResp raised USD 2 million in seed funding, led by Concrete Ventures and Invest Nova Scotia.

NovaResp provides a cMAP™, which is an artificial intelligence-based medical software that is mainly used in continuous positive airway pressure (CPAP) machines and offers respiratory monitoring and therapy solutions. The company's platform uses machine-learning algorithms to prevent respiratory failure in individuals with sleep apnea and other respiratory diseases.

The company plans to use the seed funds raised in January 2023 to accelerate its product development, regulatory approval, and other pre-commercialization efforts.

## Funding rounds

- Seed, May 15, 2024, $3M — Invest Nova Scotia, Concrete Ventures
- Seed, Jan 26, 2023, $2M — Concrete Ventures, Invest Nova Scotia

## Investors

- Concrete Ventures (https://capitalatlas.ai/funds/concrete-ventures) — Seed
- Invest Nova Scotia — Seed